Skip to main content
Sebastian Alexander Mayer, MD, Oncology, New York, NY, New York-Presbyterian Hospital

Sebastian AlexanderAMayerMD

Oncology New York, NY

Hematologic Oncology

Associate Professor, Clinical Medicine, Weill Cornell Medical College

Dr. Mayer is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Mayer's full profile

Already have an account?

Education & Training

  • Memorial Sloan-Kettering Cancer Center
    Memorial Sloan-Kettering Cancer CenterFellowship, Bone Marrow and Stem Cell Transplantation, 2007 - 2008
  • Mount Sinai School of Medicine
    Mount Sinai School of MedicineFellowship, Hematology/Oncology, 2003 - 2006
  • Mount Sinai St. Luke's - West Hospital Center
    Mount Sinai St. Luke's - West Hospital CenterResidency, Internal Medicine, 2000 - 2003
  • University of Vienna Faculty of Medicine
    University of Vienna Faculty of MedicineClass of 1998
  • Vienna School of EconomicsBachelor's, Economics, 1988 - 1992
  • Munich UniversityNo Degree, Physics, 1987 - 1988

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2015 - 2023
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Best Resident of the Internal Medicine Clinic Award St. Luke's-Roosevelt Hospital Center, 2001
  • MED-PRO Award for Best Free Paper 23rd International Symposium on Radioactive Isotopes in Clinical Medicine and Research, Bad Gastein, Austria, 1998

Publications & Presentations

PubMed

Journal Articles

  • Comparison of Subcutaneous versus Intravenous Alemtuzumab for Graft-versus-Host Disease Prophylaxis with Fludarabine/Melphalan Based Conditioning in Matched Unrelated ...  
    Patel K, Parmar S, Shah S, Shore T, Gergis U, Mayer S, van Besien K, Biol Blood Marrow Transplant, 1/30/2015
  • FAM treatment for new onset bronchiolitis obliterans syndrome after hematopoietic cell transplantation  
    Kirsten M. Williams, Guang-Shing Cheng, Iskra Pusic, Madan Jagasia, Linda Burns, Vincent T. Ho, Joseph Pidala, Jeanne Palmer, Laura Johnston, Sebastian Mayer, Jason W...., Biol Blood Marrow Transplant, 1/22/2015
  • A randomized phase II crossover study of imatinib or rituximab for cutaneous sclerosis after hematopoietic cell transplantation  
    Arai S, Pidala J, Pusic I, Chai X, Jaglowski S, Khera N, Palmer J, Chen GL, Jagasia M, Mayer SA, Wood WA, Green M, Hyun TS, Inamoto Y, Storer BE, Miklos DB, Shulman HM..., Clin Cancer Res, 1/16/2015
  • Join now to see all

Books/Book Chapters

Lectures

  • Hematopoietic Stem Cell Transplant in Novel Agent Era Is Associated with Improved Survival in Relapsed and Refractory Peripheral T-Cell Lymphoma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Does Presence of Persistent Molecular Mutations Matter in AML Patients Undergoing Allogeneic Stem Cell Transplant? 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • CCR5 delta32 Cord & Haploidentical Grafts: Allogeneic Stem Cell Transplant for HIV+ /AML Patient: A Case Report from the Impaact P1107 Observational StudyClinically Re... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Professional Memberships

Other Languages

  • German, French

Hospital Affiliations